Abstract
Purpose: NICE guidance [1] recommends patients with muscle invasive bladder cancer (MIBC) suitable for radical treatment be offered a choice between cystectomy and radiotherapy. A randomised controlled trial was not feasible, in part due to a lack of clinician equipoise [2]. Despite NICE guidance there is evidence of variation in practice across UK centres. We undertook a qualitative exploration of decision-making from the perspectives of patients, carers and clinicians. This forms part of a mixed-methods study investigating quality of life (QoL) after radical treatment for MIBC (Q-ABC) [3].
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
